Induction chemotherapy using paclitaxel, carboplatin, CPT-11 [irinotecan] with pegfilgrastim support followed by conformal radiotherapy and paclitaxel/carboplatin/ZD1839 (IRESSA) [gefitinib] in locally advanced unresectable stage IIIA/B non-small cell carcinoma of the lung.
Latest Information Update: 12 Feb 2013
At a glance
- Drugs Carboplatin (Primary) ; Gefitinib (Primary) ; Irinotecan (Primary) ; Paclitaxel (Primary) ; Pegfilgrastim (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Feb 2012 Actual patient number is 24 according to ClinicalTrials.gov.
- 21 Feb 2012 Actual patient number is 24 according to ClinicalTrials.gov.
- 21 Feb 2012 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.